Pramlintide (Symlin) studies: 145 papers with results
Page 3 of 3
- Ex vivo human placental transfer of the peptides pramlintide and exenatide (synthetic exendin-4).
Hiles RA · Human & experimental toxicology · 2003
Ex vivo tissue · 1 result
- Pramlintide Antagonizes Beta Amyloid (Aβ)- and Human Amylin-Induced Depression of Hippocampal Long-Term Potentiation.
Kimura R · Molecular neurobiology · 2017
Ex vivo tissue · mouse · 5 results
- Islet amyloid polypeptide toxicity and membrane interactions.
Cao P · Proceedings of the National Academy of Sciences of the United States of America · 2013
In vitro (cells) · 2 results
- Activity of pramlintide, rat and human amylin but not Aβ1-42 at human amylin receptors.
Gingell JJ · Endocrinology · 2014
In vitro (cells) · 4 results
- Pramlintide regulation of extracellular matrix (ECM) and apoptosis through mitochondrial-dependent pathways in human nucleus pulposus cells.
Wu X · International journal of immunopathology and pharmacology · 2018
In vitro (cells) · 12 results
- Pramlintide, an antidiabetic, is antineoplastic in colorectal cancer and synergizes with conventional chemotherapy.
Al-Keilani MS · Clinical pharmacology : advances and applications · 2018
In vitro (cells) · 5 results
- Contraction of human brain vascular pericytes in response to islet amyloid polypeptide is reversed by pramlintide.
Nuñez-Diaz C · Molecular brain · 2023
In vitro (cells) · 1 result
- Pramlintide: An Amylin Analogue Protects Endothelial Cells against Oxidative Stress through Regulating Oxidative Markers and NF-κb Expression.
Safaeian L · International journal of preventive medicine · 2022
In vitro (cells) · 7 results
- Development of the novel amylin and calcitonin receptor activators by peptide mutagenesis.
Lee S · Archives of biochemistry and biophysics · 2024
In vitro (cells) · 2 results
- The effect of pramlintide, an antidiabetic amylin analogue, on angiogenesis-related markers in vitro.
Safaeian L · Research in pharmaceutical sciences · 2020
In vitro (cells) · 6 results
- Amylin receptor agonism enhances the effects of liraglutide in protecting against the acute metabolic side effects of olanzapine.
Medak KD · iScience · 2024
Other design · 8 results
- A co-formulation of pramlintide and insulin A21G (ADO09) improves postprandial glucose and short-term control of mean glucose, time in range, and body weight versus insulin aspart in adults with type 1 diabetes.
Andersen G · Diabetes, obesity & metabolism · 2023
Not a test of Pramlintide (Symlin) alone · 11 results
- Enhanced weight loss following coadministration of pramlintide with sibutramine or phentermine in a multicenter trial.
Aronne LJ · Obesity (Silver Spring, Md.) · 2010
Not a test of Pramlintide (Symlin) alone · 10 results
- A Phase 2 Evaluation of a Novel Co-Formulation of Pramlintide and Regular Insulin to Improve Postprandial Glycemic Control in Adults with Type 1 Diabetes (T1D)
Edelman S · Journal of the Endocrine Society · 2021
Not a test of Pramlintide (Symlin) alone · 10 results
- ADO09, a co-formulation of the amylin analogue pramlintide and the insulin analogue A21G, lowers postprandial blood glucose versus insulin lispro in type 1 diabetes.
Andersen G · Diabetes, obesity & metabolism · 2021
Not a test of Pramlintide (Symlin) alone · 7 results
- Combined GLP-1 Receptor Agonist and Amylin Analogue Pharmacotherapy to Treat Obesity Comorbid With Type 1 Diabetes.
Wong G · JCEM case reports · 2023
Not a test of Pramlintide (Symlin) alone · 10 results
- ADO09, a co-formulation of pramlintide and insulin A21G, lowers body weight versus insulin lispro in type 1 diabetes.
Andersen G · Diabetes, obesity & metabolism · 2024
Not a test of Pramlintide (Symlin) alone · 6 results
- A Pilot Outpatient Assessment of a Fully Closed-Loop Insulin and Pramlintide System.
Odabassian M · Journal of diabetes science and technology · 2025
Not a test of Pramlintide (Symlin) alone · 6 results
- Properties of pramlintide and insulin upon mixing.
Weyer C · American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists · 2005
Not a test of Pramlintide (Symlin) alone · 5 results
- Simple meal announcements and pramlintide delivery versus carbohydrate counting in type 1 diabetes with automated fast-acting insulin aspart delivery: a randomised crossover trial in Montreal, Canada.
Cohen E · The Lancet. Digital health · 2024
Not a test of Pramlintide (Symlin) alone · 5 results
- Fully Automated Artificial Pancreas for Adults With Type 1 Diabetes Using Multiple Hormones: Exploratory Experiments.
Majdpour D · Canadian journal of diabetes · 2021
Not a test of Pramlintide (Symlin) alone · 5 results
- Ultra-Fast Insulin-Pramlintide Co-Formulation for Improved Glucose Management in Diabetic Rats.
Maikawa CL · Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2021
Not a test of Pramlintide (Symlin) alone · 5 results
- Involvement of amylin B-H2S-connexin 43 signaling pathway in vascular dysfunction and enhanced ischemia-reperfusion-induced myocardial injury in diabetic rats.
Liu X · Bioscience reports · 2020
Not a test of Pramlintide (Symlin) alone · 5 results
- Systemic Pharmacokinetic Principles of Therapeutic Peptides.
Nordell P · Clinical pharmacokinetics · 2026
Not a test of Pramlintide (Symlin) alone · 22 results
- A co-formulation of supramolecularly stabilized insulin and pramlintide enhances mealtime glucagon suppression in diabetic pigs.
Maikawa CL · Nature biomedical engineering · 2020
Not a test of Pramlintide (Symlin) alone · 4 results
- A fully artificial pancreas versus a hybrid artificial pancreas for type 1 diabetes: a single-centre, open-label, randomised controlled, crossover, non-inferiority trial.
Tsoukas MA · The Lancet. Digital health · 2021
Not a test of Pramlintide (Symlin) alone · 4 results
- Zn(II) binding to pramlintide results in a structural kink, fibril formation and antifungal activity.
Dudek D · Scientific reports · 2022
Not a test of Pramlintide (Symlin) alone · 4 results
- A temperature-responsive dual-hormone foam nanoengine improves rectal absorptivity of insulin-pramlintide for diabetes treatment.
Feng S · Science advances · 2024
Not a test of Pramlintide (Symlin) alone · 4 results
- Comparison of the post-meal glucose response to different insulin bolus waveforms in insulin pump- and pre-meal pramlintide-treated type 1 diabetes patients.
King AB · Diabetes technology & therapeutics · 2010
Not a test of Pramlintide (Symlin) alone · 4 results
- In silico design of optimal ratio for co-administration of pramlintide and insulin in type 1 diabetes.
Micheletto F · Diabetes technology & therapeutics · 2013
Not a test of Pramlintide (Symlin) alone · 3 results
- Reducing postprandial hyperglycemia with adjuvant premeal pramlintide and postmeal insulin in children with type 1 diabetes mellitus.
Hassan K · Pediatric diabetes · 2009
Not a test of Pramlintide (Symlin) alone · 3 results
- Effect of proline mutations on the monomer conformations of amylin.
Chiu CC · Biophysical journal · 2013
Not a test of Pramlintide (Symlin) alone · 2 results
- Rationally designed, nontoxic, nonamyloidogenic analogues of human islet amyloid polypeptide with improved solubility.
Wang H · Biochemistry · 2014
Not a test of Pramlintide (Symlin) alone · 2 results
- Fusion Outcomes of GLP-1 Agonist Therapy in Multilevel Cervical Spinal Fusion: A Propensity-Matched Analysis.
Vatsia SK · Clinical spine surgery · 2025
Not a test of Pramlintide (Symlin) alone · 8 results
- Complete characterization of the mutation landscape reveals the effect on amylin stability and amyloidogenicity.
Smaoui MR · Proteins · 2015
Not a test of Pramlintide (Symlin) alone · 2 results
- INTERACTIONS OF METFORMIN AND OTHER MEDICATIONS IN REDUCING THE ODDS OF AGE-RELATED MACULAR DEGENERATION IN A COHORT OF PATIENTS WITH DIABETES.
Shaw L · Retina (Philadelphia, Pa.) · 2024
Not a test of Pramlintide (Symlin) alone · 2 results
- A model of glucose-insulin-pramlintide pharmacokinetics and pharmacodynamics in type I diabetes.
Ramkissoon CM · Journal of diabetes science and technology · 2014
Not a test of Pramlintide (Symlin) alone · 2 results
- A model of subcutaneous pramlintide pharmacokinetics and its effect on gastric emptying: Proof-of-concept based on populational data.
Furió-Novejarque C · Computer methods and programs in biomedicine · 2024
Not a test of Pramlintide (Symlin) alone · 2 results
- Leptin responsiveness restored by amylin agonism in diet-induced obesity: evidence from nonclinical and clinical studies.
Roth JD · Proceedings of the National Academy of Sciences of the United States of America · 2008
Not a test of Pramlintide (Symlin) alone · 1 result
- A closed-loop synthetic gene circuit for the treatment of diet-induced obesity in mice.
Rössger K · Nature communications · 2013
Not a test of Pramlintide (Symlin) alone · 1 result
- Analysis of the ability of pramlintide to inhibit amyloid formation by human islet amyloid polypeptide reveals a balance between optimal recognition and reduced amyloidogenicity.
Wang H · Biochemistry · 2015
Not a test of Pramlintide (Symlin) alone · 1 result
- Structural effects driven by rare point mutations in amylin hormone, the type II diabetes-associated peptide.
Mendes WS · Biochimica et biophysica acta. General subjects · 2021
Not a test of Pramlintide (Symlin) alone · 1 result
- Synergistic long-range effects of mutations underlie aggregation propensities of amylin analogues.
Alves NA · Journal of molecular modeling · 2019
Not a test of Pramlintide (Symlin) alone · 1 result
- Case Series of Nizon-Isidor Syndrome by Heterozygous Variants in MED12L With Further Evidence of Mitotic Instability in One Case With Diploid-Triploid Mosaicism.
Stewart R · American journal of medical genetics. Part A · 2026
Not a test of Pramlintide (Symlin) alone · 2 results
- In silico evaluation of pramlintide dosing algorithms in artificial pancreas systems.
Pons Torres B · Computers in biology and medicine · 2025
Not a test of Pramlintide (Symlin) alone · 1 result